Growth Metrics

Catheter Precision (VTAK) Non-Current Deffered Revenue (2017 - 2021)

Catheter Precision (VTAK) has disclosed Non-Current Deffered Revenue for 5 consecutive years, with $566000.0 as the latest value for Q2 2021.

  • Quarterly Non-Current Deffered Revenue fell 33.1% to $566000.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $566000.0 through Jun 2021, down 33.1% year-over-year, with the annual reading at $686000.0 for FY2020, 44.32% down from the prior year.
  • Non-Current Deffered Revenue for Q2 2021 was $566000.0 at Catheter Precision, down from $617000.0 in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $1.2 million in Q4 2019, with the low at $566000.0 in Q2 2021.
  • Average Non-Current Deffered Revenue over 5 years is $853153.8, with a median of $775000.0 recorded in 2017.
  • The sharpest move saw Non-Current Deffered Revenue soared 60.63% in 2019, then crashed 44.32% in 2020.
  • Over 5 years, Non-Current Deffered Revenue stood at $775000.0 in 2017, then fell by 1.03% to $767000.0 in 2018, then skyrocketed by 60.63% to $1.2 million in 2019, then plummeted by 44.32% to $686000.0 in 2020, then decreased by 17.49% to $566000.0 in 2021.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $566000.0, $617000.0, and $686000.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.